| HLA-independent T cell receptors for targeting tumors with low antigen density J Mansilla-Soto, J Eyquem, S Haubner, M Hamieh, J Feucht, N Paillon, ... Nature medicine 28 (2), 345-352, 2022 | 95 | 2022 |
| CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience KA Frerichs, NA Nagy, PL Lindenbergh, P Bosman, J Marin Soto, ... Expert Review of Clinical Immunology 14 (3), 197-206, 2018 | 52 | 2018 |
| Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells SJC van der Stegen, PL Lindenbergh, RM Petrovic, H Xie, MP Diop, ... Nature Biomedical Engineering 6 (11), 1284-1297, 2022 | 36 | 2022 |
| FT819: translation of off-the-shelf TCR-Less Trac-1XX CAR-T cells in support of first-of-kind phase I clinical trial C Chang, S Van der Stegen, M Mili, R Clarke, YS Lai, A Witty, ... Blood 134, 4434, 2019 | 20 | 2019 |
| Development of anti-CD32b antibodies with enhanced fc function for the treatment of B and plasma cell malignancies H Lu, RD Molony, D Chen, S Jang, B Wolf, S Ewert, M Flaherty, F Xu, ... Molecular cancer therapeutics 19 (10), 2089-2104, 2020 | 5 | 2020 |
| NOTCH and CAR Signaling Control T Cell Lineage Commitment From Pluripotent Stem Cells S Van der Stegen, P Lindenbergh, R Petrovic, B Whitlock, R Clarke, ... Blood 136, 30, 2020 | 3 | 2020 |
| Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies A Dobrin, PL Lindenbergh, Y Shi, K Perica, H Xie, N Jain, A Chow, ... Nature Cancer, 1-14, 2024 | 2 | 2024 |
| The Development of Allogeneic Tips-Derived TCR-CAR+ CD8αβ T Cells SJC van der Stegen, RM Petrovic, PL Lindenbergh, MP Diop, V Alexeeva, ... Blood 140 (Supplement 1), 10290-10291, 2022 | | 2022 |
| 132 HLA-independent T cell receptors effectively target low abundance antigens J Mansilla-Soto, J Eyquem, S Haubner, M Hamieh, J Feucht, N Paillon, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A142-A142, 2021 | | 2021 |
| Generation of novel single cell-derived engineered master pluripotent cell line as a renewable source for off-the-shelf TCR-less CAR T cells in support of first-of-kind … R Abujarour, YS Lai, M Pribadi, T Lee, M Robinson, C Ruller, ... CANCER RESEARCH 79 (13), 2019 | | 2019 |
| Abstract LB-073: Generation of novel single cell-derived engineered master pluripotent cell line as a renewable source for off-the-shelf TCR-less CAR T cells in support of … R Abujarour, YS Lai, M Pribadi, T Lee, M Robinson, C Ruller, SV Stegen, ... Cancer Research 79 (13_Supplement), LB-073-LB-073, 2019 | | 2019 |
